SEC Form 4 · accession 0001214659-26-010723
Twist Bioscience Corp · TWST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Cho
Officer — See Remarks
Period of report
Aug 19, 2026
Accepted (ET)
Aug 21, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001581280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 19, 2026 | S | 14,205 | $129.75 | D | 75,661 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2026.
Remarks
Senior Vice President, Chief Legal Officer & Corporate Secretary